Literature DB >> 21040483

Screening for type 2 diabetes with random finger-prick glucose and bedside HbA1c in an Australian emergency department.

George A Jelinek1, Tracey J Weiland, Gaye Moore, Grace Tan, Marg Maslin, Kath Bowman, Glenn Ward, Kerin O'Dea.   

Abstract

OBJECTIVE: To determine if screening for undiagnosed type 2 diabetes mellitus (T2DM) and pre-diabetes is feasible in an Australian ED; to estimate the prevalence of T2DM and pre-diabetes in the Australian ED population.
METHODS: Prospective cross-sectional prevalence survey in the ED of St Vincent's Hospital, Melbourne, an adult, tertiary referral centre seeing approximately 40,000 patients annually. A convenience sample of adult patients was screened with finger-prick random blood glucose and glycosylated haemoglobin (HbA1c); those over 6.0 mmol/L and 6.0% were referred for oral glucose tolerance test (OGTT). Diagnoses of T2DM and pre-diabetes were made according to World Health Organization definitions. Those not attending for OGTT were contacted by phone, and interviewed about their reasons.
RESULTS: Seven hundred and twenty-five patients were recruited; 135 (18.6%; 95% confidence intervals [CI] 15.9-21.6%) had known T2DM, leaving 590 screened, of whom 210 screened positive. Of the 192 referred for OGTT, 147 (77%) did not attend despite several telephone reminders. Of the 45 (23%) completing OGTT, pre-diabetes was present in eight (17.8%; 95% CI 9.0-31.6%) and T2DM in six (13.3%; 95% CI 5.9-26.6%). Many people interviewed (18/86, 21%) did not attend for OGTT on the advice of their doctors.
CONCLUSIONS: This inner city tertiary ED has a high prevalence of T2DM, diagnosed and undiagnosed, with over a quarter of our population probably affected [corrected]. Although ED screening might have a high yield, opportunistic screening is not feasible, with difficulties in staff engagement and patient follow up for diagnostic testing. Future studies might consider finger-prick fasting blood glucose through a patient's general practitioner for diagnosis.
© 2010 The Authors. Emergency Medicine Australasia © 2010 Australasian College for Emergency Medicine and Australasian Society for Emergency Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040483     DOI: 10.1111/j.1742-6723.2010.01333.x

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  5 in total

1.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

2.  Stress hyperglycaemia in hospitalised patients and their 3-year risk of diabetes: a Scottish retrospective cohort study.

Authors:  David A McAllister; Katherine A Hughes; Nazir Lone; Nicholas L Mills; Naveed Sattar; John McKnight; Sarah H Wild
Journal:  PLoS Med       Date:  2014-08-19       Impact factor: 11.069

3.  Undiagnosed Diabetes in Patients Admitted to a Clinical Decision Unit from the Emergency Department: A Retrospective Review.

Authors:  Jessica Sop; Mark Gustafson; Clyde Rorrer; Alfred Tager; Frank H Annie
Journal:  Cureus       Date:  2018-10-01

4.  Diabetes case finding in the emergency department, using HbA1c: an opportunity to improve diabetes detection, prevention, and care.

Authors:  Tien-Ming Hng; Amanda Hor; Sumathy Ravi; Xiaoqi Feng; Jaime Lin; Thomas Astell-Burt; David Chipps; Mark McLean; Glen Maberly
Journal:  BMJ Open Diabetes Res Care       Date:  2016-06-03

Review 5.  Assessment of glycaemic status in adult hospital patients for the detection of undiagnosed diabetes mellitus: A systematic review.

Authors:  Tabitha D Thornton-Swan; Laura C Armitage; Aisling M Curtis; Andrew J Farmer
Journal:  Diabet Med       Date:  2022-01-05       Impact factor: 4.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.